- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Belgian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
3
0 new
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
3 companies
Hyloris Pharmaceuticals
Market Cap: €159.0m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.76
7D
-3.7%
1Y
-50.8%
UCB
Market Cap: €29.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€155.25
7D
-3.3%
1Y
22.7%
argenx
Market Cap: €31.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€513.00
7D
-0.7%
1Y
52.1%